Unraveling Stories Connecting Communities
Image Credit: Adobe Stock Images/J lee Topline Findings Outpatient Treatment Potential: Epkinly may allow safe administration of relapsed or refractory…
Jim Reilly, president, Development Cloud, and EVP, global strategy, Veeva Image Credit: Andy Studna In the opening keynote of the…
Image Credit: Adobe Stock Images/Olga Gorkun Topline Findings Oral PCSK9 Inhibitor Innovation: Enlicitide decanoate is the first oral macrocyclic peptide…
Image Credit: Adobe Stock Images/wutzkoh Roche and Alnylam are launching the Phase III ZENITH cardiovascular outcomes trial (CVOT) to evaluate…
Image Credit: Adobe Stock Images/lovelyday12 Topline Findings Verquvo in chronic heart failure and reduced ejection fraction (HFrEF): Verquvo (vericiguat) continues…
© photon_photo – © photon_photo – stock.adobe.com What clinops professionals need to know Funding cuts in clinical research are tightening…
This is the Applied Clinical Trials Brief—your fast track to the latest insights in clinical research operations. In under three…
Image Credit: Adobe Stock Images/Fitry Topline Findings Phase III CYPRESS Enrollment Completed: Theravance Biopharma finishes open-label patient enrollment in the…
Lipset: Clearly, this is a very polarizing time politically for a lot of folks, but I think objectively, most would…
Credit: Dzmitry | stock.adobe.com Infants with spinal muscular atrophy (SMA) administered early treatment with Evrysdi (risdiplam) demonstrated motor milestone achievements that…
Credit: photon_photo | stock.adobe.com Background Clinical trial success depends on selecting appropriate clinical sites. Poor site selection can lead to…
In a recent video interview with Applied Clinical Trials, Sunny Kumar, MD, partner, Informed Ventures, discussed the slow adoption of…
Credit: kentoh | stock.adobe.com Decentralized clinic trials are more than a mere trend, they are a revolution in the ways…
In a recent video interview with Applied Clinical Trials, Sunny Kumar, MD, partner, Informed Ventures, discussed the slow adoption of…
Credit: Proxima Studio | stock.adobe.com As GLP-1 therapies expand from diabetes into obesity, cardiovascular disease, and rare conditions, clinical trial…
Image Credit: © JHVEPhoto – stock.adobe.com For individuals who fall outside of the conditions listed under the new CDC recommendations,…
Image Credit: Adobe Stock Images/Robin What clinops professionals need to know The Phase III NIMBLE trial demonstrated that cemdisiran, given…
In a recent video interview with Applied Clinical Trials, Sunny Kumar, MD, partner, Informed Ventures, discussed the slow adoption of…
Image Credit: Adobe Stock Images/MKS The FDA has granted Breakthrough Therapy Designation (BTD) to Genmab’s Rina-S (rinatabart sesutecan) for the…
Image Credit: © JHVEPhoto – stock.adobe.com What clinops professionals need to know The FDA will now publish FAERS adverse event…
Image Credit: © Shuo – stock.adobe.com What clinops professionals need to know Early-stage research is vulnerable to bias due to…
In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network…
Image Credit: © Pixel-Shot – stock.adobe.com Nicox has shared positive results from the Phase III Denali clinical trial (NCT04630808) evaluating…
In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network…
Image Credit: © WESTOCK – stock.adobe.com What clinops professionals need to know Recent NIH funding cuts tied to DEI policies…
Image Credit: Adobe Stock Images/Suriyawut Topline Findings Z-1018 Shingles Vaccine Shows Comparable Immunity: In part 1 of the Phase I/II…
This presentation was generated based on two articles written by Rebecca Johnson, PhD: The Impact of DEI Ban On Clinical…
Image Credit: © Production Perig – stock.adobe.com ImmunityBio has initiated a new Phase II study, COVID-4.019-Long (NCT07123727), to evaluate the…
Image Credit: Adobe Stock Images/Ti Studio Topline Findings Primary Endpoint Not Met: Barzolvolimab did not improve eosinophilic esophagitis (EoE) symptoms,…
This is the Applied Clinical Trials Brief—your fast track to the latest insights in clinical research operations. In under three…
Image Credit: Adobe Stock Images/nature_photo by ice Topline Findings FDA lifts clinical hold on RP-A501 trial: Rocket Pharmaceuticals’ pivotal Phase…
In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network…
Image Credit: © Dr_Microbe – stock.adobe.com What clinops professionals need to know The Phase II trial is evaluating Hepzato in…
In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network…
Image Credit: Adobe Stock Images/Bartek Topline Findings FDA Breakthrough Therapy Designation (BTD): I-DXd (ifinatamab deruxtecan) receives FDA BTD for pretreated…
Rohit Nambisan, CEO, Lokavant Jonathan Crowther, head of predictive analytics, Pfizer Summary AI adoption in clinical operations is accelerating, with…
In a recent video interview with Applied Clinical Trials, Meri Beckwith, Co-CEO, Lindus Health, discussed the evolving perception of breakthrough…
In a recent interview with Applied Clinical Trials, Ron Lanton, partner at Lanton Law, discussed the pivotal role clinical operations…
Alan Baldridge, MD, Senior Director, Gastroenterology and Hepatology, Drug Development Solutions, ICON What clinops professionals need to know A 2025…
Image Credit: Adobe Stock Images/Vii Topline Findings First Patient Treated: Apreo Health has enrolled the first patient in the pivotal…
Image Credit: © Pixel-Shot – stock.adobe.com What clinops professionals need to know The Phase II STARLIGHT trial evaluated a single…
Image credit: © Destina – stock.adobe.com What clinops professionals need to know The Phase II B-SUPREME trial is evaluating ALG-000184,…
Image Credit: Adobe Stock Images/Sean Topline Findings VE202 Phase II Results: Vedanta Biosciences’ VE202 did not meet the trial’s primary…
This is the Applied Clinical Trials Brief—your fast track to the latest insights in clinical research operations. In under three…
In a recent interview with Applied Clinical Trials, Jon Walsh, founder and chief scientific officer of Unlearn, discussed how AI-designed…
Image Credit: © AkuAku – stock.adobe.com Summary The Phase III VAYHIT2 trial evaluated ianalumab plus eltrombopag versus placebo plus eltrombopag…
Image Credit: © Matthieu – stock.adobe.com Summary The Phase III EV-303/KEYNOTE-905 trial showed that Padcev (enfortumab vedotin) plus Keytruda (pembrolizumab),…
In a recent interview with Applied Clinical Trials, Jon Walsh, founder and chief scientific officer of Unlearn, discussed how AI-designed…
Image Credit: Adobe Stock Images/Magnimage Topline Findings First Patient Dosed: Biogen and Stoke Therapeutics initiate Phase III EMPEROR trial of…
Image Credit: © Satjawat – stock.adobe.com Summary The TRIUMpH Phase III program demonstrated that tegoprazan maintained healing in GERD patients…
Image Credit: Adobe Stock Images/freebird7977 Topline Findings Orforglipron delivers strong weight loss results: Lilly’s oral GLP-1 candidate achieved up to…
In a recent video interview with Applied Clinical Trials, Luke Wilson, senior director, biotech, pharma services, Thermo Fisher Scientific, discussed…
Image Credit: © Kaikoro – stock.adobe.com Summary AI-powered, unified digital platforms are streamlining non-interventional studies by removing site dependencies, accelerating…
Image Credit: © Matthieu – stock.adobe.com Summary The Phase III ENVISION trial 24-month update shows Zusduri maintained a 72.2% duration…
Image Credit: Adobe Stock Images/Johannes Topline Findings Positive Phase III Trial Results: Genmab’s Epkinly (epcoritamab) combined with Rituxan (rituximab) and…
In a recent interview with Applied Clinical Trials, Jon Walsh, founder and chief scientific officer of Unlearn, discussed how AI-designed…
In a recent video interview with Applied Clinical Trials, Luke Wilson, senior director, biotech, pharma services, Thermo Fisher Scientific, discussed…
Credit: Lars Neumann | stock.adobe.com Summary The FDA has endorsed further development of Immutep’s eftilagimod alfa (efti) in combination with…
Image Credit: © Tada Images – stock.adobe.com Summary HHS has canceled 22 BARDA-funded mRNA vaccine contracts, totaling $500 million, as…
Cindy Henderson, chief strategy officer, Veristat Summary Protocol complexity is rising across therapeutic areas, driving costly delays and frequent amendments—now…
In a recent video interview with Applied Clinical Trials, Luke Wilson, senior director, biotech, pharma services, Thermo Fisher Scientific, discussed…
In a recent video interview with Applied Clinical Trials, Luke Wilson, senior director, biotech, pharma services, Thermo Fisher Scientific, discussed…
Image Credit: © photon_photo – stock.adobe.com Key takeaways Nearly 70% of Phase II trials fail, often due to preventable issues…
This is the Applied Clinical Trials Brief—your fast track to the latest insights in clinical research operations. In under three…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Key takeaways The 30 mg onvansertib arm demonstrated a 49% confirmed ORR versus…
In a recent video interview with Applied Clinical Trials, Michael Miller, chief operating officer, Quanterix, discussed how the clinical research…
Image Credit: Adobe Stock Images/Pete Key Takeaways FDA Approval for JSKN003 Trial: Alphamab Oncology received FDA approval to start a…
Image Credit: © Dr_Microbe – stock.adobe.com Key takeaways Monthly ivermectin administration reduced malaria incidence by 26% versus albendazole, meeting WHO…
Image Credit: Adobe Stock Images/MUdaylah Key takeaways Obicetrapib 10 mg significantly reduced plasma p-tau217 levels over 12 months in both…
Image Credit: Adobe Stock Images/Orawan Key Takeaways Sustained Benefit Over Three Years: Kisunla continued to slow cognitive and functional decline…
Image Credit: © Axel Bueckert – stock.adobe.com Key takeaways Repibresib missed both primary and key secondary endpoints in Phase IIb,…
Credit: Alex Papp | stock.adobe.com Key takeaways Robust primary endpoint success: Upadacitinib achieved ≥80% scalp hair coverage in over half…
Image Credit: © chayantorn – stock.adobe.com Key takeaways The AMPLIFY trial supports a fixed-duration, all-oral regimen of venetoclax and acalabrutinib,…
Credit: and.one | stock.adobe.com Key takeaways J&J has submitted an sBLA to the FDA seeking to update Tremfya’s label to…
Credit: Andrii | stock.adobe.com Key takeaways Ilumya demonstrated statistically significant ACR20 responses at Week 24 in both biologic-experienced and biologic-naïve…
Rudradev Sengupta, Senior Trial Design Lead at One2Treat Key takeaways Net treatment benefit (NTB) provides a more holistic, multidimensional assessment…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Key takeaways Final FLAURA2 data show Tagrisso plus chemotherapy significantly improves overall survival…
Image Credit: Adobe Stock Images/jam Key Takeaways Clinical trial searches are delaying treatment: Around 72% of physicians in the United…
In a recent video interview with Applied Clinical Trials, Kate Gallin Heffernan, life sciences attorney, Epstein Becker Green, discussed the…
In a recent video interview with Applied Clinical Trials, Kate Gallin Heffernan, life sciences attorney, Epstein Becker Green, discussed the…
Image Credit: Adobe Stock Images/Robin Key Takeaways Gefurulimab shows promise in generalized myasthenia gravis (gMG) treatment: Phase III PREVAIL trial…
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways Expect heightened scrutiny of trial design: Recent CRLs underscore that even previously…
Image Credit: Adobe Stock Images/Bungon Key Takeaways Obefazimod delivers statistically significant clinical remission in Ulcerative Colitis (UC): The 50 mg…
Image Credit: © peterschreiber.media – stock.adobe.com Key takeaways The ALIENTO Phase IIb study met its primary endpoint, demonstrating a 15.4%…
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways FDA’s internal AI assistant, Elsa, has experienced accuracy issues, including generating false…
In a recent video interview with Applied Clinical Trials, Kate Gallin Heffernan, life sciences attorney, Epstein Becker Green, discussed the…
In a recent video interview with Applied Clinical Trials, Kate Gallin, Heffernan, life sciences attorney, Epstein Becker Green, discussed the…
In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of pediatrics…
Image Credit: © Pixel-Shot – stock.adobe.com Key takeaways The MR-139 blepharitis trial missed its primary endpoint, prompting reevaluation of future…
Image Credit: Adobe Stock Images/Jorm Sangsorn Key Takeaways Online recruitment boosts trial efficiency and diversity: Social media platforms such as…
In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of…
In a recent video interview with Applied Clinical Trials, Ramita Tandon, chief biopharma officer, Walgreens, discussed the company’s three-year milestone…
In a recent video interview with Applied Clinical Trials, Ramita Tandon, chief biopharma officer, Walgreens, discussed the company’s three-year milestone…
In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of…
Image Credit: © Ezume Images – stock.adobe.com Key takeaways 89% of eligible participants in the VOLITION trial chose to switch…
Image Credit: Adobe Stock Images/Khella Key Takeaways ODAC vote raises safety concerns over Blenrep combinations: FDA advisory panel cited significant…
Image Credit: Adobe Stock Images/Nurillo Key Takeaways Twice-yearly pre-exposure prophylaxis (PrEP) shows strong efficacy: Yeztugo prevented HIV infections in pregnant…
Image Crddit: © yanapopovaiv – stock.adobe.com Key takeaways The Phase III CARES program evaluating anselamimab did not meet its primary…
Image Credit: © stockdevil – stock.adobe.com Key takeaways Interim analysis from the randomized Phase IIb SURVIVE trial supports continued evaluation…
Image Credit: Adobe Stock Images/Green Creator Key Takeaways Azer-cel shows strong response rates in relapsed/refractory diffuse large B-cell lymphoma (DLBCL):…
Image Credit: © cacaroot – stock.adobe.com Key takeaways Phase II data show avexitide significantly reduces Level 2 and 3 hypoglycemic…
In a recent video interview with Applied Clinical Trials, Ramita Tandon, chief biopharma officer, Walgreens, discussed the company’s three-year milestone…
Image Credit: © Ezume Images – stock.adobe.com Key takeaways Merck has launched the Phase III EXPrESSIVE program to evaluate MK-8527,…
In a recent video interview with Applied Clinical Trials, Ramita Tandon, chief biopharma officer, Walgreens, discussed the company’s three-year milestone…
Image Credit: © Proxima Studio – stock.adobe.com Key takeaways Once-weekly efsitora may streamline insulin initiation for insulin-naïve type 2 diabetes…
Image Credit: Adobe Stock Images/MohammedElAmine Key Takeaways Xtandi plus leuprolide significantly improves overall survival: In patients with non-metastatic hormone-sensitive prostate…
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and…
Image Credit: Adobe Stock Images/Tada Images Key Takeaways FDA publishes over 200 complete response letters (CRLs): The agency released CRLs…
Gaurav Bhatnagar, Chief Growth Officer, Tilda Research In an era where artificial intelligence (AI) writes poetry, self-driving cars navigate complex…
Image Credit: © Matthieu – stock.adobe.com Key takeaways Orphan drug designation for quemliclustat highlights regulatory momentum and unmet need in…
Image Credit: © Dr_Microbe – stock.adobe.com Key takeaways Large-Scale, Multinational Trial Design: The P304 study enrolled over 40,000 participants across…
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and…
Image Credit: © Aerial Mike – stock.adobe.com Key takeaways Long-term ENLIVEN data reinforce the value of extended follow-up in rare…
Credit: steph photographies | stock.adobe.com Key Takeaways Perioperative Immunotherapy Boosts EFS. The KEYNOTE-689 trial demonstrated that adding neoadjuvant and adjuvant…
Christine Senn, PhD, FACRP is the SVP of Site-Sponsor Innovation at Advarra Key takeaways Modernize processes for site-initiated ads: Sponsors…
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and…
Credit: magicmine | stock.adobe.com Key takeaways The expanded FDA approval of Farapulse introduces a non-thermal ablation option for persistent AF,…
Credit: Egor | stock.adobe.com Key Takeaways AI and Machine Learning Are Revolutionizing Trial Design. Artificial intelligence (AI) and machine learning…
With the EMA adopting ICH E6(R3) in July, sponsors with EU trial operations must now meet stricter regulations that directly…
In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer, uMotif, discussed how the company actively incorporates patient…
April 30th 2025 Article We are amidst a data revolution in healthcare and the life sciences. With advances in DNA…
Image Credit: © rost9 – stock.adobe.com Key takeaways Rare disease trial design requires careful structuring: The GEMZ trial’s two-part, multi-phase…
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…
Credit: samunella | stock.adobe.com Key takeaways Early trial termination for efficacy signals strong clinical benefit: The ZENITH trial was halted…
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…
Image Credit: © putilov_denis – stock.adobe.com Key takeaways Automation must evolve into intelligence: Traditional automation has reached its limits—future-ready trials…
Image Credit: Adobe Stock Images/mi_viri Key Takeaways Bemarituzumab Shows Survival Benefit: The Phase III FORTITUDE-101 trial met its primary endpoint,…
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…
Image Credit: © photon_photo – stock.adobe.com Key takeaways Clinical trial populations often don’t reflect the diversity or complexity of real-world…
Credit: Daniel Krasoń | stock.adobe.com. Key Takeaways Unprecedented Weight Loss Outcomes. In the REDEFINE 1 trial, 60% of participants receiving…
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…
Credit: Crystal light | stock.adobe.com Key Takeaways First Phase III Trial for Felzartamab in PMN: Biogen has initiated dosing in…
April 30th 2025 Article We are amidst a data revolution in healthcare and the life sciences. With advances in DNA…
April 30th 2025 Article We are amidst a data revolution in healthcare and the life sciences. With advances in DNA…
Credit: Sebastian Kaulitzki | stock.adobe.com Key Takeaways Missed Primary Endpoint at 36 Weeks. Efruxifermin did not significantly reduce fibrosis without…
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts…
Shadi Cinpinski, MHA, Director, Therapeutic Strategy, Oncology, IQVIA Jim Routt, Vice President and Unit Head, Oncology Global Therapeutic Delivery, IQVIA…
Credit: David A Litman | stock.adobe.com. Key Takeaways High Overall Response Rate. Talvey and Tecvayli combination achieved a 78.9% overall…
Image Credit: © Design Cells – stock.adobe.com Key takeaways Strong Prophylactic Efficacy: Hympavzi achieved a 93% reduction in annualized bleeding…
Key takeaways Data and AI are redefining clinical trial operations, requiring end-to-end data strategies, trustworthy AI frameworks, and a shift…
Credit: Key design | stock.adobe.com. Higher-Dose Semaglutide Shows Enhanced Efficacy Key Takeaways Higher-Dose Semaglutide Shows Enhanced Efficacy. The investigational 7.2…
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent…
Image Credit: © putilov_denis – stock.adobe.com Key takeaways Tokenization enhances real-world evidence integration: Tokenization enables researchers to securely link clinical…
Credit: New Africa | stock.adobe.com Key Takeaways Up to 20% Weight Loss Achieved with Monthly Dosing. MariTide demonstrated mean weight…
Eric Karofsky is an award-winning CX, UX, and employee engagement industry expert who leads VectorHX, a human experience agency. Key…
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent…
Credit: Tada Images | stock.adobe.com Key Takeaways FDA fast-tracks reviews for priority drugs: The new Commissioner’s National Priority Voucher (CNPV)…
At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the underrecognized but impactful role of the public sector—particularly the…
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent…
At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the under-recognized but impactful role of the public sector—particularly the…
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent…
Credit: steph photographies | stock.adobe.com Key Takeaways Elinzanetant Significantly Reduces Vasomotor Symptoms. Patients receiving elinzanetant experienced a statistically significant reduction…
At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the underrecognized but impactful role of the public sector—particularly the…
Credit: Lisa | stock.adobe.com Key Takeaways Breyanzi Achieves High Overall Response Rate in R/R MZL. In the Phase II TRANSCEND FL…
In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer, uMotif, discussed how the company actively incorporates patient…
Image Credit: © photon_photo – stock.adobe.com Key takeaways Wearable ECG devices are transforming cardiac safety monitoring by enabling continuous, real-world…
At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the underrecognized but impactful role of the public sector—particularly the…
In a recent video interview with Applied Clinical Trials, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer…
ACT: What are some of the most exciting themes or trends in clinical research you’re looking to explore at this…
Megan Bailey, EVP and president of central laboratories and international, Labcorp Key takeaways Central labs are becoming strategic trial partners,…
In a recent video interview with Applied Clinical Trials, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer…
Image Credit: © Murrstock – stock.adobe.com “Identifying … potential data manipulation and data integrity problems” are an International Council for…
In a recent video interview with Applied Clinical Trials, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer…
Credit: Andrii | stock.adobe.com Key Takeaways Sotyktu Meets Primary Endpoint in POETYK PsA-1 Trial. In the Phase III POETYK PsA-1…
Rebecca Johnson, PhD, Clinical Research Recruitment and Inclusion Executive and Strategist Key Takeaways Progress toward inclusive trials without mandates. Even…
Allison Cuff Shimooka, Chief Operating Officer, TransCelerate BioPharma Key Takeaways Clinical trial processes lag behind scientific and technological advances. While…
Over the last half a century or so, clinical research has progressively shifted from a somewhat paternalistic focus on physiological…
Hugo Stephenson, MD, Co-Founder and Executive Chair, TrialScreen Key Takeaways Eligibility ≠ participation. While many users meet trial eligibility criteria,…
Graham Bell Director, Global Regulatory Strategy, ICON plc Key Takeaways Joint Clinical Assessment is now a parallel requirement under HTAR.Health…
Credit: and.one | stock.adobe.com Key Takeaways Tremfya Reduces Structural Joint Damage in PsA. Phase IIIb APEX trial results show that…
Image Credit: © LASZLO – stock.adobe.com Key takeaways Phase III Trial Explores Enhertu Combo in Endometrial Cancer: DESTINY-Endometrial01 is assessing…
In a recent video interview with Applied Clinical Trials, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discussed…
Image Credit: © putilov_denis – stock.adobe.com Key takeaways Transparent FMV practices are critical: Open and collaborative FMV calculations help build…
In a recent video interview with Applied Clinical Trials, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discussed…
In a recent video interview with Applied Clinical Trials, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discussed…
Image Credit: © photon_photo – stock.adobe.com Key takeaways Early regulatory engagement prevents delays: Proactively managing protocol amendments and aligning with…
Join us for an insightful session IQVIA experts Anthony Mikulaschek and Michael Bruhns will share their experience on harnessing the…
Credit: Saiful52 | stock.adobe.com Key Takeaways On-body delivery system (OBDS) proves non-inferior to IV Sarclisa in multiple myeloma treatment. Data…
Image Credit: © Crystal light – stock.adobe.com Key takeaways Promising interim results support APRIL inhibition as a viable IgAN strategy:…
In a recent video interview with Applied Clinical Trials, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discussed…
Image Credit: Adobe Stock Images/freshidea Key Takeaways Carvykti Delivers Long-Term Remission: One-third of patients in the CARTITUDE-1 trial achieved at…
In a recent video interview with Applied Clinical Trials, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discussed…
Image Credit: © Tada Images – stock.adobe.com Key takeaways HHS has pulled a $590M grant from Moderna’s H5N1 mRNA flu…
Credit: Sebastian Kaulitzki | stock.adobe.com Key Takeaways First-Line Survival Milestone in BRAF V600E mCRCThe Braftovi (encorafenib) combination regimen is the…
Image Credit: © iDoPixBox – stock.adobe.com Key takeaways Tecentriq plus Zepzelca significantly improved both PFS and OS in ES-SCLC maintenance…
In a recent video interview with Applied Clinical Trials, Ron Lanton, partner, Lanton Law, discussed the impact of drug cost…
Image Credit: © Crystal light – stock.adobe.com Key takeaways Enhertu plus pertuzumab showed a 44% reduction in disease progression or…
Introduction Paper-based data capture has been the standard in clinical trials since their inception. In the 1990s, the FDA kicked…
Jennifer Ross, director of biostatistics, and Kevin Venner, group leader, biostatisticians; both with Almac Clinical Technologies Developing a clinical trial’s…
Image Credit: © Dr_Microbe – stock.adobe.com Key takeaways Early-phase trial design should anticipate combination therapy pathways, as seen with MK-1084…
In a recent video interview with Applied Clinical Trials, Ron Lanton, partner, Lanton Law, discussed the impact of drug cost…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Key takeaways BLA withdrawn due to lack of OS benefit: The Phase III…
© photon_photo – © photon_photo – stock.adobe.com. Key takeaways AI and tech expertise are becoming core clin ops requirements: Success…
Image Credit: © Crystal light – stock.adobe.com Key takeaways Trodelvy achieves primary endpoint in first-line mTNBC: The ASCENT-03 Phase III…
Image Credit: © Aerial Mike – stock.adobe.com Key takeaways Strong ORR validates trial design and execution: The trial achieved a…
Image Credit: © Dr_Microbe – stock.adobe.com Key takeaways Quality of life metrics matter in mCSPC trials: Post-hoc ARANOTE data shows…
In a recent video interview with Applied Clinical Trials, Michel van Harten, MD, CEO, myTomorrows, discussed the integration of artificial…
Don’t miss IQVIA Technologies’ webinar on clinical trial budgeting. Gain insights into effective budget-building techniques and explore how IQVIA GrantPlan…
Credit: Johannes | stock.adobe.com Key Takeaways Phase III IDeate-Esophageal01 Trial LaunchesMerck and Daiichi Sankyo have initiated a global, multicenter Phase…
